|
Apr 5
|
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
|
|
Mar 25
|
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
|
|
Mar 4
|
Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
|
|
Nov 27
|
Zacks Industry Outlook Highlights Medpace, Doximity and Biodesix
|
|
Nov 7
|
Biodesix Announces Third Quarter 2023 Results and Highlights
|
|
Aug 26
|
Jack Schuler Spends US$217k On Biodesix Stock
|
|
Jun 27
|
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
|
|
Apr 27
|
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
|